There are other long-term risks associated with Ocrevus and patients with active hepatitis B or are allergic to Ocrevus are not advised to begin the therapy. Other side effects include:
Infections: Ocrevus increases the risk of infections such as respiratory infections, herpes, and skin infections.
Reactivating hepatitis B virus: You should speak to your healthcare team if you’ve had hepatitis B.
Progressive multifocal leukoencephalopathy (PML): Although no patient on the clinical trials for Ocrevus developed this rare brain infection, there is a risk that this could occur.
A weakened immune system: If Ocrevus is taken with other multiple sclerosis medications it may lead to a weakened immune system and leave patients more susceptible to infections.
Cancer: Ocrevus may increase your risk of developing certain types of cancer, including breast cancer. You will need to ensure you have regular cancer screenings.
Multiple Sclerosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
We are sorry that this post was not useful for you!
Let us improve this post!
Tell us how we can improve this post?